Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -57.2% | -12.8% | 1 / 3 | +8.5% | -4.69 pp | -10.47 pp | +21.0% | 0.44 | 13.97 | 214 | +8,5% | 14,6 | −57,2% | 13.97 | 13.67 | +2,2% |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 35.400 (close price on 2026-10-19)EPS (TTM): 2.534
Financial charts
1.Revenue & growth
VND bn214Q2/26
1.Revenue & growth
VND bn214Q2/26
2.Profit & growth
VND bn14,6Q2/26
3.Profit mix (Penman)
VND bn128Q2/26
4.Margins & cost structure
%28.0%Q2/26
5.Returns & cash cycle
% · days18.6%Q2/26
6.Earnings quality & cash
VND bn163Q2/26
7.Asset structure
VND bn745Q2/26
8.Funding & debt health
VND bn · times745Q2/26
9.Revenue backlog
VND bn5,98Q2/26
10.Valuation
times · %15,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %384Q2/26
Adjusted EPS growth, latest quarter
-57.2%
Average adjusted EPS growth, 3 quarters
-12.8%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26